Medicine and Dentistry
Prostate Cancer
100%
Androgen Deprivation Therapy
38%
Meta-Analysis
25%
Chemical Imaging
19%
Penile Cancer
18%
Abiraterone
17%
Neoplasm
17%
Prostate Biopsy
16%
Metastatic Carcinoma
15%
Hazard Ratio
12%
Hormone Therapy
11%
Lymph Node
10%
Retroperitoneal Lymph Node Dissection
10%
Androgen Receptor
10%
Fresh Frozen Plasma
10%
Prostatectomy
9%
Diagnostic Accuracy
9%
Randomized Controlled Trial
9%
Enzalutamide
8%
All Cause Mortality
8%
Adverse Event
8%
Nonsteroid Antiinflammatory Agent
8%
Biopsy
7%
Clear Cell Renal Cell Carcinoma
7%
Cohort Analysis
7%
Cancer Surgery
7%
Abiraterone Acetate
7%
Disorders of Mitochondrial Functions
7%
Genetic Counseling
7%
Minimally Invasive Procedure
7%
Lower Urinary Tract Symptom
7%
Multiparametric Magnetic Resonance Imaging
7%
Transcriptome
7%
Succinate Dehydrogenase
7%
Surgical Margin
7%
Tenofovir
7%
Mosaicism
7%
Cancer Mortality
7%
Surgery
7%
Intraepithelial Neoplasia
7%
Recurrent Disease
7%
Prednisolone
7%
Penis Carcinoma
7%
Urinary Tract Infection
7%
Penis Cancer
7%
Laser Microscopy
7%
Tissue Microarray
7%
Spectroscopic Imaging
7%
Hyperspectral Image
7%
Cancer Tissue
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
46%
Androgen
23%
Androgen Receptor
17%
Deep Vein Thrombosis
15%
Antibiotics
11%
Disease
10%
Abiraterone
8%
Adverse Event
8%
Transcriptome
7%
Antibiotic Agent
7%
Lower Urinary Tract Symptom
7%
Tenofovir
7%
Molecularly Imprinted Polymer
7%
Cancer Mortality
7%
Urinary Tract Infection
7%
Tenofovir Disoproxil
7%
Non-Steroidal Anti-Inflammatory Drug
7%
Disorders of Mitochondrial Functions
7%
Neoplasm
7%
Penis Cancer
7%
Metastasis
5%
Malignant Neoplasm
5%